In this UCSF Medical Grand Rounds presentation (June 11, 2020), UCSF experts provide an update on the epidemiology for COVID-19 and the next phase of the pandemic. They also highlight the shift to speed in publications and the FDA approval process – raising the question of whether safety is being compromised. The session is hosted by UCSF Department of Medicine chair Bob Wachter.
Program
Bob Wachter: Introduction
00:05:41 – George Rutherford, Professor, Dept. of Epidemiology & Biostatistics, UCSF; Director of the Prevention and Public Health Group – Update in Epidemiology and the New Phase of the Pandemic
00:22:53 – Q&A
00:29:37 – A panel discussion with Dr. Rutherford and the speakers below – The Shift to Speed in Publications and the FDA Approval Process: An Appropriate Response to a Pandemic or Setup for Errors?
• Rob Califf, Director of Medical Strategy and Policy, Verily and Google Health; former Commissioner of the US Food & Drug Administration; and Founding Director of the Duke Clinical Research Institute (DCRI)
• Vinay Prasad, Associate Professor, Depts. of Epidemiology & Biostatistics and Medicine, UCSF; and author of Ending Medical Reversal and Malignant: How Bad Policy and Bad Evidence Harm People with Cancer
• Rita Redberg, Professor of Medicine, Division of Cardiology, UCSF; and Editor, JAMA Internal Medicine
01:15:43 – Bob Wachter: Closing
See previous Covid-19 Medical Grand Rounds:
• June 4: The Covid-19 Pandemic in the Context of the Healthcare System, Economy, Race, Politics, Ethics, and History
• May 28: Update on Covid-19: Testing, ICU Practices and Outcomes at ZSFG, and the Experience of Elders in the Covid-19 Pandemic
• May 21: Update on Covid-19: Epidemiology, Treatments and Vaccines, Thromboembolic Complications, and the Multisystem Inflammatory Syndrome Affecting Children
• May 14: Covid-19 Update: The ICU Experience in New York, the UCSF Mission and Bolinas Community Studies, and the Uses and Limitations of Antibody Testing
See all UCSF Covid-19 grand rounds here:
